elranatamab will increase the level or influence of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Elranatamab causes cytokine release syndrome (CRS) that could suppress action of CYP enzymes, leading to enhanced publicity of CYP substrates.The fentanyl skin patch is just employed for opioi